Under construction – not a live service
Sign in
Taking people in FranceNo phase

Yoga Therapy Compared With Physiotherapy for Axial Spondyloarthritis

Compares yoga therapy with physiotherapy in adults with moderate axial spondyloarthritis, a form of arthritis.

Plain-language title generated from the registry record
Registry title: Effects of Yoga Therapy in Rehabilitation Compared to Physiotherapy in Moderate Axial Spondyloarthritis (axSPA)

Key facts

Where
Bobigny, Créteil, and Paris, FranceSee the 4 sites

Where in France

  • Hopital AvicenneBobigny, FranceTaking people
  • Hopital Henri MondorCréteil, FranceNo longer taking part
  • Hôpital CochinParis, FranceTaking people
  • Hopital Pitie-SalpetriereParis, FranceNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Assistance Publique - Hôpitaux de Paris
Trial code
NCT06083090
Record updated
1 October 2025
Original description
A few studies have evaluated the effectiveness of yoga therapy in patients with axial spondyloarthritis (axSPA). On the other hand, studies conducted in other chronic rheumatisms such as low back pain, rheumatoid arthritis or other conditions such as cancer have shown that yogatherapy can have a effective action on the physical and psychological level.Read full original descriptionShow less

Effects of Yoga Therapy in Rehabilitation Compared to Physiotherapy in Moderate Axial Spondyloarthritis (axSPA): a Randomized Controlled Multicenter Study.

A few studies have evaluated the effectiveness of yoga therapy in patients with axial spondyloarthritis (axSPA). On the other hand, studies conducted in other chronic rheumatisms such as low back pain, rheumatoid arthritis or other conditions such as cancer have shown that yogatherapy can have a effective action on the physical and psychological level.

Yogatherapy is a non-drug "body-mind" approach that would be likely to improve the physical symptoms (pain, stiffness, in particular spinal and pelvic), internal organs (colitis) and psychological symptoms as well as the perception of fatigue of people with axSPA. A 2021 study showed the feasibility and acceptability of regular yogatherapy practice in patients with axSPA.

It is therefore necessary to conduct randomized controlled studies to assess the effectiveness of this management strategy.

Inclusion: French-speaking patient aged 18 and over; Patient with axial spondyloarthritis (axSPA) according to Assessment of SpondyloArthritis International Society, diagnosed by a rheumatologist; "Moderately active" to "active" form of axSPA (basic BASDAI \> 3); Stable disease: No recent or foreseeable introduction in the next 6 months of drug treatments for axSPA (excluding analgesics); Absence of disabling stress urinary incontinence; Geographical or organizational possibility of undergoing the study; Patient informed and having signed the informed consent form for participation in the research.

Exclusion: Abdominal or spinal surgery in the last six months; Depressive syndrome requiring specific treatment; Pregnancy or breastfeeding; Recent childbirth (within the last six months); Patient already practicing yoga or having practiced it in the last six months; Motor neurological deficit; Sphincter deficit; Any other somatic pathology preventing the practice of physiotherapy or yogatherapy according to the opinion of the evaluating clinician; Non-affiliation to a social security scheme (beneficiary or beneficiary) or to another social protection scheme; Patient deprived of liberty by judicial or administrative decision or under legal protection (guardianship, safeguard of justice); Currently participating in or in a period of exclusion from: another interventional research involving human participants, a clinical trial on a medical product for human, a clinical investigation on a medical device. Participation in non-interventional research is authorized.

ClinicalTrials.gov NCT06083090